Last reviewed · How we verify
NCT06796140
Photoprotection Efficacy of a Sunscreen Under Visible Light Exposure by Using Two Different Simulators
trial testing Visible Light Exposure - Treated zone - Left hemi-back in Visible Light Exposures on Healthy Back Skin in 15 participants. Completed in 9 April 2021.
9 April 2021
Quick facts
| Lead sponsor | Cosmetique Active International |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 8 March 2021 |
| Primary completion | 9 April 2021 |
| Estimated completion | 9 April 2021 |
| Sites | 1 location across Romania |
Drugs / interventions tested
- Visible Light Exposure - Treated zone - Left hemi-back
- Visible Light Exposure - Treated zone - Right hemi-back
- Visible Light Exposure - Untreated zone - Left hemi-back
- Visible Light Exposure - Untreated zone - Right hemi-back
Conditions studied
- Visible Light Exposures on Healthy Back Skin — all drugs for Visible Light Exposures on Healthy Back Skin →
Sponsor
Cosmetique Active International — full company profile →
Who can join
Adults 18 to 50, any sex, with Visible Light Exposures on Healthy Back Skin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the ability of a protected agent to prevent the pigmentation under visible light exposures (VL) using two different simulators in healthy volunteers
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Visible Light-Induced Pigmentation: Improved In Vivo Methodology for Measuring Efficacy of 30 Products in 9 Randomised Controlled Trials and Correlation With In Vitro Assessment.
Renoux P, Jouni H, Laloux C, Touti R, et al · · 2025 · cited 3× · PMID 40922539 · DOI 10.1111/exd.70167
Verify or expand the search:
- PubMed search for NCT06796140
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cosmetique Active International trials
Trials by the same sponsor.
- NCT07239726 — CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPI · NA · not yet recruiting
- NCT06590779 — Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss · NA · not yet recruiting
- NCT06516224 — Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma · NA · not yet recruiting
- NCT07537595 — Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) [400-450nm] · completed
- NCT06320314 — Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06796140 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cosmetique Active International
- Last refreshed: 30 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06796140.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing